Evidence map›Paper›PMID 24691607›Full record

SynthesisJAMA2014

Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis.

Jeffrey M Rohde, Derek E Dimcheff, Neil Blumberg, Sanjay Saint, Kenneth M Langa, Latoya Kuhn, Andrew Hickner, Mary A M Rogers

Erratum issued Registry-linked trialOpen access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in JAMA, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05699005 (Comparison of an Individualized Transfusion Strategy to a Conventional Strategy in Patients Undergoing Peripheral Veno-arterial ECMO for Refractory Cardiogenic Shock), which is not on this map. Cited by 217 papers, 24 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
217citing papers in PubMed, 24 pooled it
44.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05699005 phase1recruitingnot on this mapstarted 2023, after this paper: background citation

Comparison of an Individualized Transfusion Strategy to a Conventional Strategy in Patients Undergoing Peripheral Veno-arterial ECMO for Refractory Cardiogenic Shock: a Randomized Controlled Trial - ICONE

TypeinterventionalSponsorUniversity Hospital, LilleRan2023 to 2028Enrolled236ConditionsCardiogenic Shock, Extracorporeal Membrane Oxygenation, Transfusion Related Complication, AnemiaArmsPacked Red Blood Cells (PRBCs)
3 · Its place in the literature

Who cites it

217 citing papers in PubMed, 24 syntheses or guidelines pooled it, 604 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Treatment for women with postpartum iron deficiency anaemia.The Cochrane database of systematic reviews · 2024
    Pooled it
  6. Prophylactic red blood cell transfusions in children and neonates with cancer: An evidence-based clinical practice guideline.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Guideline
  7. Pooled it
  8. Pooled it
  9. Transfusion thresholds for guiding red blood cell transfusion.The Cochrane database of systematic reviews · 2021
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

157 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jeffrey M RohdeUniversity of Michigan, Division of General Medicine, Department of Internal Medicine, Ann Arbor.
Derek E DimcheffUniversity of Michigan, Division of General Medicine, Department of Internal Medicine, Ann Arbor.
Neil BlumbergDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.
Sanjay SaintUniversity of Michigan, Division of General Medicine, Department of Internal Medicine, Ann Arbor3VA Ann Arbor Medical Center/University of Michigan Patient Safety Enhancement Program, Ann Arbor4VA Ann Arbor Health Services Research and Development Center.
Kenneth M LangaUniversity of Michigan, Division of General Medicine, Department of Internal Medicine, Ann Arbor3VA Ann Arbor Medical Center/University of Michigan Patient Safety Enhancement Program, Ann Arbor4VA Ann Arbor Health Services Research and Development Center.
Latoya KuhnVA Ann Arbor Medical Center/University of Michigan Patient Safety Enhancement Program, Ann Arbor4VA Ann Arbor Health Services Research and Development Center of Excellence, Ann Arbor, Michigan.
Andrew HicknerUniversity of Michigan, Division of General Medicine, Department of Internal Medicine, Ann Arbor3VA Ann Arbor Medical Center/University of Michigan Patient Safety Enhancement Program, Ann Arbor.
Mary A M RogersUniversity of Michigan, Division of General Medicine, Department of Internal Medicine, Ann Arbor3VA Ann Arbor Medical Center/University of Michigan Patient Safety Enhancement Program, Ann Arbor5Institute for Healthcare Policy and Innovation, University of.
University of Michigan–Ann Arbor · USMichigan Medicine · USAnn Arbor VA Medical Center · USUniversity of Rochester Medical Center · US

Funding

Blood Transfusions: Gender Differences in Utilization, Predictors, and OutcomesR21HL093129 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROGERS, MARY A. M. · 2009 to 2010
$438k
NHLBI NIH HHS 5R21HL093129-02NHLBI NIH HHS R21 HL093129
6 · The paper itself

Abstract

importanceThe association between red blood cell (RBC) transfusion strategies and health care-associated infection is not fully understood.

objectiveTo evaluate whether RBC transfusion thresholds are associated with the risk of infection and whether risk is independent of leukocyte reduction. DATA SOURCES: MEDLINE, EMBASE, Web of Science Core Collection, Cochrane Central Register of Controlled Trials, Cochrane Database of Sytematic Reviews, ClinicalTrials.gov, International Clinical Trials Registry, and the International Standard Randomized Controlled Trial Number register were searched through January 22, 2014. STUDY SELECTION: Randomized clinical trials with restrictive vs liberal RBC transfusion strategies. DATA EXTRACTION AND SYNTHESIS: Twenty-one randomized trials with 8735 patients met eligibility criteria, of which 18 trials (n = 7593 patients) contained sufficient information for meta-analyses. DerSimonian and Laird random-effects models were used to report pooled risk ratios. Absolute risks of infection were calculated using the profile likelihood random-effects method. MAIN OUTCOMES AND MEASURES: Incidence of health care-associated infection such as pneumonia, mediastinitis, wound infection, and sepsis.

resultsThe pooled risk of all serious infections was 11.8% (95% CI, 7.0%-16.7%) in the restrictive group and 16.9% (95% CI, 8.9%-25.4%) in the liberal group. The risk ratio (RR) for the association between transfusion strategies and serious infection was 0.82 (95% CI, 0.72-0.95) with little heterogeneity (I2 = 0%; τ2 <.0001). The number needed to treat (NNT) with restrictive strategies to prevent serious infection was 38 (95% CI, 24-122). The risk of infection remained reduced with a restrictive strategy, even with leukocyte reduction (RR, 0.80 [95% CI, 0.67-0.95]). For trials with a restrictive hemoglobin threshold of <7.0 g/dL, the RR was 0.82 (95% CI, 0.70-0.97) with NNT of 20 (95% CI, 12-133). With stratification by patient type, the RR was 0.70 (95% CI, 0.54-0.91) in patients undergoing orthopedic surgery and 0.51 (95% CI, 0.28-0.95) in patients presenting with sepsis. There were no significant differences in the incidence of infection by RBC threshold for patients with cardiac disease, the critically ill, those with acute upper gastrointestinal bleeding, or for infants with low birth weight. CONCLUSIONS AND RELEVANCE: Among hospitalized patients, a restrictive RBC transfusion strategy was associated with a reduced risk of health care-associated infection compared with a liberal transfusion strategy. Implementing restrictive strategies may have the potential to lower the incidence of health care-associated infection.

Indexed as

Erythrocyte TransfusionCross InfectionHumansMediastinitisPneumoniaRandomized Controlled Trials as TopicRiskSepsisSurgical Wound Infection

Identifiers

PMID24691607
PMCPMC4289152
OpenAlexW2163332984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.